Physician profile
Michael J Doermann
NPI 1548645195
$955.33
in general payments reported to CMS, 2019-2025
12 companies · $13.79 in 2025
The $13.79 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $14.02 · 2021: $32.63 · 2022: $282 · 2023: $454 · 2024: $159 · 2025: $13.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $627.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $627.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $401.04 | 2021-2024 | Freestyle Libre 3 |
| Insulet Corporation | $249.26 | 2023 | Omnipod |
| Beta Bionics, INC. | $146.93 | 2023-2024 | Ilet Bionic Pancreas |
| Dexcom, INC. | $32.93 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $21.00 | 2022 | |
| Novo Nordisk INC | $17.44 | 2023 | Ozempic, Rybelsus |
| Lilly USA, LLC | $17.10 | 2023 | Mounjaro |
| Abbvie INC. | $14.63 | 2021 | |
| Tandem Diabetes Care, INC. | $14.21 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Medtronic Minimed, INC. | $14.02 | 2020 | |
| Sequel Med Tech, LLC | $13.79 | 2025 | Twiist |
| Bayer Healthcare Pharmaceuticals INC. | $12.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Doermann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.